{
    "patient_id": "P-90210",
    "name": "Robert Smith",
    "age": 65,
    "weight_kg": 82,
    "height_cm": 175,
    "medical_conditions": [
        "Atrial Fibrillation",
        "Hypertension",
        "Type 2 Diabetes"
    ],
    "current_medications": [
        {
            "name": "Warfarin",
            "dosage": "5mg",
            "frequency": "Once daily",
            "purpose": "Anticoagulation for AFib",
            "start_date": "2023-06-15"
        },
        {
            "name": "Lisinopril",
            "dosage": "10mg",
            "frequency": "Once daily",
            "purpose": "Blood pressure control",
            "start_date": "2022-03-20"
        },
        {
            "name": "Metformin",
            "dosage": "500mg",
            "frequency": "Twice daily",
            "purpose": "Blood sugar control",
            "start_date": "2021-11-10"
        }
    ],
    "allergies": [
        {
            "allergen": "Penicillin",
            "reaction": "Rash and swelling"
        }
    ],
    "recent_labs": {
        "date": "2024-10-15",
        "INR": 2.3,
        "creatinine": 1.1,
        "HbA1c": 6.8
    },
    "vital_signs": {
        "blood_pressure": "138/82",
        "heart_rate": 72,
        "temperature": 36.8
    },
    "clinical_notes": [
        {
            "date": "2024-10-15",
            "note": "Patient reports good medication compliance. No bleeding episodes. INR therapeutic."
        },
        {
            "date": "2025-11-22 10:58",
            "note": "Patient has a significant drug-drug interaction risk between Paracetamol and Warfarin, which can potentiate the anticoagulant effect and increase the risk of bleeding. Initiating Paracetamol requires a mandatory INR check within 3-5 days and close monitoring for any signs of bleeding. Counseled patient on risks."
        }
    ],
    "last_visit": "2024-10-15"
}